Research Participation in Substance Use Disorder Trials: Design and Methods of a Multi-Site Nested Qualitative Study

• Published in: International journal of qualitative methods Vol. 21; p. 160940692211311
• Main Authors: Richardson, Lindsey, Jaffe, Kaitlyn, Socias, M. Eugenia, Le Foll, Bernard, Lim, Ron, Jutras-Aswad, Didier
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.09.2022; Sage Publications Ltd; SAGE Publishing
• Subjects: Addictions; Analgesics; Buprenorphine; Clinical research; Clinical trials; Criminalization; Disorders; Drug use; Marginality; Medical research; Medicine; Methadone; Naloxone; Narcotics; Opioids; Participation; Poverty; Qualitative research; Recruitment; Stigma; Substance abuse; Substance use disorder; Treatment methods; opioid use disorder; addiction medicine; qualitative nested study; RCT participation
• ISSN: 1609-4069; 1609-4069
• DOI: 10.1177/16094069221131168

Background Given the health and social harms of problematic substance use, randomized controlled trials (RCTs) are critical in developing and testing pharmacotherapies for substance use disorders. However, substance use RCTs can be challenging to conduct, considering the social and structural barriers to participating in research among people with substance use disorders (PSUD), including stigma, poverty, and criminalization—factors that can shape trial recruitment, enrollment, protocol adherence and study retention. Despite these barriers, adequate representation and participation of PSUD in RCT research is essential to assessing and developing treatments, and thus a deeper understanding of RCT participation dynamics among PSUD is needed to support clinical trial research. Methods We conducted a nested qualitative study within a Canadian, multisite, phase IV, open-label, pragmatic RCT that tested two approved opioid agonist treatments, methadone and buprenorphine/naloxone, among patients with prescription opioid use disorder. A subset of individuals (n = 60) participating in this RCT were interviewed across four different regions in Canada at the beginning and end of their trial involvement, as well as study clinicians (n = 16) and staff (n = 16) operating the trial. Conclusion As a nested study within a real-world addiction medicine trial, this research offers an innovative approach to investigating the experiences, strategies, and challenges associated with RCTs among PSUD. While we acknowledge challenges related to the operations of multisite research and engaging marginalized populations in experimental research, this study has the potential to generate critical insights around the RCT experiences of PSUDs and trial staff to inform the conduct of future RCTs.